Torrent Pharma Q1 net profit rises 20% on broad-based growth

Torrent Pharmaceuticals reported a robust 20% increase in net profit, reaching Rs 548 crore for Q1 FY26, fueled by strong performances in India, the US, and Brazil. Consolidated revenue grew by 11% to Rs 3,178 crore, with operating EBITDA rising 14% to Rs 1,032 crore. The India business saw an 11% revenue increase, driven by chronic therapies.